Measuring single cell divisions in human tissues from multi-region sequencing data.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 02 2020
Historique:
received: 05 09 2019
accepted: 29 01 2020
entrez: 27 2 2020
pubmed: 27 2 2020
medline: 23 5 2020
Statut: epublish

Résumé

Both normal tissue development and cancer growth are driven by a branching process of cell division and mutation accumulation that leads to intra-tissue genetic heterogeneity. However, quantifying somatic evolution in humans remains challenging. Here, we show that multi-sample genomic data from a single time point of normal and cancer tissues contains information on single-cell divisions. We present a new theoretical framework that, applied to whole-genome sequencing data of healthy tissue and cancer, allows inferring the mutation rate and the cell survival/death rate per division. On average, we found that cells accumulate 1.14 mutations per cell division in healthy haematopoiesis and 1.37 mutations per division in brain development. In both tissues, cell survival was maximal during early development. Analysis of 131 biopsies from 16 tumours showed 4 to 100 times increased mutation rates compared to healthy development and substantial inter-patient variation of cell survival/death rates.

Identifiants

pubmed: 32098957
doi: 10.1038/s41467-020-14844-6
pii: 10.1038/s41467-020-14844-6
pmc: PMC7042311
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035

Subventions

Organisme : Wellcome Trust
ID : 209409/Z/17/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A19771
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A22909
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202778/Z/16/Z
Pays : United Kingdom

Références

Cancer Cell. 2015 Jan 12;27(1):15-26
pubmed: 25584892
Genome Biol. 2016 May 26;17(1):113
pubmed: 27230879
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
Nat Genet. 2016 Feb;48(2):126-133
pubmed: 26656846
Trends Cancer. 2016 Jan;2(1):49-63
pubmed: 26949746
Nat Commun. 2018 May 10;9(1):1857
pubmed: 29748584
Nature. 2018 Apr;556(7702):457-462
pubmed: 29643510
PLoS Comput Biol. 2018 Jun 7;14(6):e1006233
pubmed: 29879111
Science. 2018 Feb 2;359(6375):550-555
pubmed: 29217587
Nature. 2016 Oct 13;538(7624):260-264
pubmed: 27698416
Science. 2018 Nov 23;362(6417):911-917
pubmed: 30337457
Cell. 2017 Feb 9;168(4):613-628
pubmed: 28187284
Cancer Res. 2012 Oct 1;72(19):4875-82
pubmed: 23002210
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
Nature. 2012 Jun 28;486(7404):537-40
pubmed: 22722843
Nat Genet. 2016 Mar;48(3):238-244
pubmed: 26780609
Nat Genet. 2018 Jun;50(6):895-903
pubmed: 29808029
Cancer Discov. 2018 Oct;8(10):1270-1285
pubmed: 30166348
Nature. 2014 Oct 16;514(7522):322-7
pubmed: 25296256
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Bioinformatics. 2015 Nov 15;31(22):3673-5
pubmed: 26163694
Science. 2018 Feb 2;359(6375):555-559
pubmed: 29217584
Nat Genet. 2015 Dec;47(12):1402-7
pubmed: 26551669
Nat Commun. 2017 May 09;8:15183
pubmed: 28485371
Nat Biotechnol. 2016 Nov 8;34(11):1111-1118
pubmed: 27824834
Proc Biol Sci. 2015 May 7;282(1806):20150420
pubmed: 25876846
PLoS Comput Biol. 2016 Feb 01;12(2):e1004731
pubmed: 26828429
Annu Rev Genet. 1995;29:401-21
pubmed: 8825481
Elife. 2015 Oct 15;4:
pubmed: 26468615
PLoS Comput Biol. 2019 Jul 29;15(7):e1007243
pubmed: 31356595
Trends Genet. 2010 Aug;26(8):345-52
pubmed: 20594608
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
Genome Res. 2018 Dec;28(12):1901-1918
pubmed: 30459213
Nature. 2015 Feb 26;518(7540):542-6
pubmed: 25686605
Nature. 2018 Sep;561(7724):473-478
pubmed: 30185910
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
pubmed: 20876136
Nat Ecol Evol. 2018 Oct;2(10):1661-1672
pubmed: 30177804
Proc Natl Acad Sci U S A. 2010 Jan 26;107 Suppl 1:1725-30
pubmed: 19805033
Nat Rev Genet. 2016 Oct 14;17(11):704-714
pubmed: 27739533
Genetics. 1991 Oct;129(2):555-62
pubmed: 1743491
Nat Genet. 2014 Mar;46(3):225-233
pubmed: 24487277
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609

Auteurs

Benjamin Werner (B)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. b.werner@qmul.ac.uk.
Evolutionary Dynamics Group, Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. b.werner@qmul.ac.uk.

Jack Case (J)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
University of Cambridge, Cambridge, UK.

Marc J Williams (MJ)

Evolution and Cancer Laboratory, Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University London, London, Charterhouse Square, London, EC1M 6BQ, UK.
Department of Cell and Developmental Biology, University College London, London, UK.
Centre for Mathematics and Physics in the Life Sciences and Experimental Biology (CoMPLEX), University College London, London, UK.

Ketevan Chkhaidze (K)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.

Daniel Temko (D)

Evolution and Cancer Laboratory, Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University London, London, Charterhouse Square, London, EC1M 6BQ, UK.

Javier Fernández-Mateos (J)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.

George D Cresswell (GD)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.

Daniel Nichol (D)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.

William Cross (W)

Evolution and Cancer Laboratory, Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University London, London, Charterhouse Square, London, EC1M 6BQ, UK.

Inmaculada Spiteri (I)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.

Weini Huang (W)

Group of Theoretical Biology, The State Key Laboratory of Biocontrol, School of Life Science, Sun Yat-sen University, 510060, Guangzhou, China.
School of Mathematical Sciences, Queen Mary University London, London, UK.

Ian P M Tomlinson (IPM)

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

Chris P Barnes (CP)

Department of Cell and Developmental Biology, University College London, London, UK.
UCL Genetics Institute, University College London, London, UK.

Trevor A Graham (TA)

Evolution and Cancer Laboratory, Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University London, London, Charterhouse Square, London, EC1M 6BQ, UK. t.graham@qmul.ac.uk.

Andrea Sottoriva (A)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@icr.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH